Who has invested in Prelude Therapeutics?

No investors are named on the public record for Prelude Therapeutics yet.

Prelude Therapeutics Funding: $125M Raised, Growth (2026)

Prelude Therapeutics funding overview

Prelude Therapeutics is based in Wilmington, Delaware. Prelude Therapeutics has raised $125M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Growth announced in July 2026. The round record for Prelude Therapeutics runs through 2026; nothing later has been disclosed.

Prelude Therapeutics at a glance

Total raised: $125M
Latest round: Growth
Latest round date: July 2026
Headquarters: Wilmington, Delaware

Frequently asked about Prelude Therapeutics funding

How much has Prelude Therapeutics raised?: Prelude Therapeutics has raised $125M in total disclosed funding across the rounds on record.
Who has invested in Prelude Therapeutics?: No investors are named on the public record for Prelude Therapeutics yet.
What was the latest Prelude Therapeutics funding round?: The most recent disclosed round is a Growth, announced in July 2026.
Where is Prelude Therapeutics based?: Prelude Therapeutics is based in Wilmington, Delaware.
When did Prelude Therapeutics last raise?: The last disclosed Prelude Therapeutics round closed in July 2026 at Growth.

Round data for Prelude Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Wilmington and backer lists below.

Prelude Therapeutics Funding: $125M Raised, Growth (2026)

Prelude Therapeutics funding overview

Prelude Therapeutics at a glance

Frequently asked about Prelude Therapeutics funding

Companies related to Prelude Therapeutics (18)

Browse related funding lists (3)